Blood Clots

First case documented of vaccine-induced blood clot treated with a heparin alternative … Researchers urge improvements in kidney failure predictions for chronically ill elders … People 105 or older...

Although “extremely rare” in each case, the likelihood of a dangerous blood clot condition is eight to 10 times higher following a COVID-19 infection than it is after receiving the J&J vaccine, the...

Advisers to the CDC have released new clinical guidance and education regarding a rare blood clotting condition reported after vaccination.

Now that vaccinators are encouraged to resume giving Johnson & Johnson’s COVID-19 shot, nursing home stakeholders are questioning what effect the recent pause will have on vaccine uptake in a wary population.

Concerned LTCF staff members and residents should be aware that cases of blood clots after vaccination appear to be “extremely rare,” CMS says. Nevertheless, the agency is encouraging healthcare...

Two days after federal officials pressed pause on Johnson & Johnson’s COVID-19 vaccine, health and public policy leaders predicted it will return to use — but not without causing ongoing concern among...

CMS ends COVID blanket waivers for resident transfers and discharges, roommate changes … Imbalance in gum bacteria linked to Alzheimer’s biomarker … Risk of blood clots high following COVID hospitalization;...

Symptomless heart attacks may pose the same risk of stroke as a chest-crushing event, and are more common in people 65 and older, according to a new study to be presented at the upcoming American Stroke...

Fully 82% of seniors with atrial fibrillation in a new study experienced falls and functional disabilities. The rate of anticoagulant use decreased as the number of problems rose, researchers found.

Patients over age 80 who were not candidates for standard anticoagulant doses due to bleeding risk experienced fewer blood clots and strokes with a low daily dose of the drug edoxaban.